ID   SK-N-ER
AC   CVCL_WH10
DR   Wikidata; Q98132659
RX   PubMed=10485488;
RX   PubMed=15720811;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
RX   PubMed=10485488;
RA   Glick R.D., Swendeman S.L., Coffey D.C., Rifkind R.A., Marks P.A.,
RA   Richon V.M., La Quaglia M.P.;
RT   "Hybrid polar histone deacetylase inhibitor induces apoptosis and
RT   CD95/CD95 ligand expression in human neuroblastoma.";
RL   Cancer Res. 59:4392-4399(1999).
//
RX   PubMed=15720811; DOI=10.1593/neo.04310; PMCID=PMC1531688;
RA   Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.-F.,
RA   Biedler J.L., Cheung N.-K.V., Ross R.A.;
RT   "Characteristics of stem cells from human neuroblastoma cell lines and
RT   in tumors.";
RL   Neoplasia 6:838-845(2004).
//